<DOC>
	<DOCNO>NCT01890902</DOCNO>
	<brief_summary>The primary objective study ass analgesic efficacy Impracor ( Ketoprofen 10 % Cream ) compare placebo acute pain associate OA flare knee .</brief_summary>
	<brief_title>Efficacy Safety Impracor ( Ketoprofen 10 % Cream ) Compared With Placebo Treatment Acute Pain ( Flare ) Associated With Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<criteria>Clinical diagnosis OA knee accord ACR criterion . KellgrenLawrence grade 23 disease Be willing stop take analgesic include NSAIDs opioids duration study , exception studyspecified rescue medication . Total knee replacement surgery tentatively schedule within next 6 month . Palpable knee effusion . Significant pain outside target knee , include significant hip , back , contralateral knee pain . Any type orthopedic and/or prosthetic device skin abnormality target knee would prevent evaluation local tolerability . History asthma , rheumatoid arthritis , chronic inflammatory disease ( e.g. , colitis ) , fibromyalgia . History gastrointestinal bleeding peptic ulcer disease within past 3 year . Have positive urine drug test illegal drug substance , nonprescribed controlled substance , alcohol screening . Acute chronic illness opinion investigator could compromise integrity study data place subject risk participate study .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>